MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Re-thinking enrollment of Deep Brain Stimulation patients in Parkinson’s Disease Clinical Trials

    J. Jimenez-Shahed, J. Rosenow, S. Miocinovic, L. Luo, C. Aquino, D. Corcos, P. Agarwal (New York, USA)

    Objective: To report on a survey of Parkinson’s disease (PD) experts on the inclusion of PD patients with deep brain stimulation (DBS) in clinical trials.…
  • MDS Virtual Congress 2021

    The Effects of Telepractice- Based LSVT-BIG Training in Patients with Parkinson’s Disease in Covid-19 pandemic: Preliminary Results

    G. Kaya Aytutuldu, B. Ersoz Huseyinsinoglu, N. Karagoz Sakalli, A. Sen (İstanbul, Turkey)

    Objective: To investigate the effects of telepractice-based LSVT-BIG training on balance and mobility parameters in patients with Parkinson’s Disease (PD). Background: Patients with PD who…
  • MDS Virtual Congress 2021

    Measuring progression of Parkinson’s disease cardinal signs in the Phase 2 SPARK study

    KP. Kilambi, T. Dam, J. Edgerton, T. Fox, S. Khan, J. Xiao, M. Yang, P. Bergethon (Cambridge, USA)

    Objective: To evaluate a novel quantitative measure of Parkinson’s disease (PD) severity and progression in a Phase II clinical trial. Background: Cinpanemab, a monoclonal antibody,…
  • MDS Virtual Congress 2021

    Cinpanemab in Early Parkinson’s Disease: Phase 2 SPARK Study Results

    A. Lang, A. Siderowf, E. Macklin, W. Poewe, D. Brooks, H. Fernandez, O. Rascol, N. Giladi, F. Stocchi, C. Tanner, R. Postuma, D. Simon, E. Tolosa, B. Mollenhauer, M. Byrne, K. Fraser, J. Xiao, I. Sapir, J. Inra, R. Hutchison, M. Yang, T. Fox (Toronto, Canada)

    Objective: To evaluate cinpanemab (BIIB054) efficacy and safety. Background: Aggregated alpha-synuclein (α-syn), a major constituent of Lewy bodies, is thought to play a central role…
  • MDS Virtual Congress 2021

    Climb up! Head up! Effectiveness and feasibility of sport climbing in Parkinson’s disease

    A. Langer, H. Zach, S. Hasenauer, A. Flotz, L. Gassner, R. Pokan, P. Dabnichki, L. Wizany, D. Roth, S. Zimmel, M. Treven, M. Schmoeger, U. Willinger, W. Maetzler (Wien, Austria)

    Objective: The current study examines the effectiveness and feasibility of sport climbing in PD patients in a single-centre, randomised controlled, semi-blind trial. Background: Physical activity…
  • MDS Virtual Congress 2021

    Cuneiform Nucleus Deep Brain Stimulation for Freezing of Gait in Parkinson’s disease. Initial clinical report.

    C. Luca, S. Chang, I. Cajigas, J. Guest, I. Haq, B. Noga, J. Jagid (Miami, USA)

    Objective: Here we report a first in human targeting of Cuneiform Nucleus (CnF) using MR tractography, observation of intraoperative stimulation patterns and stimulation precision benefits of…
  • MDS Virtual Congress 2021

    Amantadine DR/ER-Related Reduction in OFF and Dyskinesia Improved Patient-Rated Interference with Activities and Social Interactions

    K. Lyons, R. Pahwa, N. Crouse, L. Llorens, R. Howard, A. Formella (Kansas City, USA)

    Objective: Evaluate dyskinesia and OFF interference with activities and experiences for persons with Parkinson disease (PWPD), and mitigation with treatment Background: OFF and Dyskinesia remain…
  • MDS Virtual Congress 2021

    Efficacy of a 6-week brisk walking program in improving non-motor symptoms in people with Parkinson disease – a randomized controlled trial

    M. Mak, ISK. Wong-Yu, LJ. Ren (Hong Kong Sar, China)

    Objective: To examine whether the brisk walking program would be effective in alleviating non-motor symptoms, and improving sleep quality and health-related quality-of-life (HRQoL) in people…
  • MDS Virtual Congress 2021

    A new fully implantable Adaptive Deep Brain Stimulation system tested for the first time in patients with Parkinson’s Disease

    T. Mandat, R. Eleopra, M. Lanotte, L. Lopiano, M. Yanssen, Y. Temel, E. Pirola, P. Rampini (Warsaw, Poland)

    Objective: This multicenter double-blind crossover study has been designed to evaluate the safety and efficacy of adaptive Deep Brain Stimulation delivered through an innovative IPG…
  • MDS Virtual Congress 2021

    Towards an automated rating of the MDS-UPDRS motor scores.

    S. Marchal, G. Garraux, S. Branders, G. Bernard, C. Billocq, A. Pereira (Mont-Saint-Guibert, Belgium)

    Objective: This study aimed at developing an automated rating method for the MDS-UPDRS motor scores in Parkinson’s disease (PD) patients. This automated rating uses inertial…
  • « Previous Page
  • 1
  • …
  • 735
  • 736
  • 737
  • 738
  • 739
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley